Skip to main content
View Cart

Journals in Cancer

Focusing on tumor biology, diagnostics, and targeted therapies, this portfolio supports oncologists, researchers, and clinicians. It features cutting-edge research, clinical trials, and personalized medicine approaches that improve patient outcomes. These resources address cancer prevention, detection, and treatment advances across all major cancer types.

  • Journal of Geriatric Oncology

    • ISSN: 1879-4068
    The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology.Editor-in-C... Supriya Mohile, University of Rochester, USA and the Editorial Board invite you to submit a manuscript to the Journal of Geriatric Oncology. The journal welcomes the submission of manuscripts in the following categories:• Original research articles • Review articles • Clinical trials • Education and training articles • Short communications • Perspectives • Meeting reports • Letters to the EditorThe Journal of Geriatric Oncology is the official journal of the International Society of Geriatric Oncology (SIOG).Journal of Geriatric Oncology's Inclusion and Diversity Pledge This journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader?ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.
    Subscriptions

  • The Journal of Molecular Diagnostics

    • ISSN: 1525-1578
    Official journal of the Association for Molecular Pathology (AMP)The Journal of Molecular Diagnostics (JMD), the official publication of the Association for Molecular Pathology (AMP), co-owned by the American Society for Investigative Pathology (ASIP), seeks to publish high quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The editors welcome for review articles that contain: novel discoveries or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, clinical informatics, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods which may be applied to diagnosis or monitoring of disease or disease predisposition.
    Subscriptions

  • Pathology - Research and Practice

    • ISSN: 0344-0338
    Pathology - Research and Practice provides accessible coverage of the most recent developments across the entire field of pathology. The Journal publishes traditional morphological studies based on histopathology, including immunohistochemistry with clinical pathological correlations, if sound biostatistical data are provided. The submission of Case Reports is only encouraged for those that provide new information on the pathogenesis of the described disease based on additional molecular biological and genetic investigations. Timely reviews that focus on recent progress in pathology are highly encouraged.A main focus of Pathology - Research and Practice is publication of manuscripts from different clinical disciplines applying molecular genetic and biological techniques and focusing on innovative results, which improve the understanding of causal pathogenesis of human diseases. Investigations for better understanding of cancer diseases and new insights into molecular carcinogenesis, including translational biology of particular cancer entities, are welcome. In this context, manuscripts focusing on new molecular genetic results, but also functional molecular biological data based on cell culture investigations and animal experiments are encouraged. With this strategy, the Journal seeks to contribute to improved understandings of human disease mechanisms.
    Subscriptions